RxDoctor Payments Data

Travis Novinger, MD

Family Medicine · Cheraw, SCNPI 1184686875

Payments from drug & device makers

$16,291in general payments, 2019–2025

Across 1,063 payments — averaging $15.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • Pfizer$902
  • Merck$740
  • plus $8K from 49 others

What the payments were for

  • Food & beverage$16,17799%
  • Education$1141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)211$2,379
Novo Nordisk121$1,647
Lilly USA, LLC92$1,313
AstraZeneca72$1,305
Pfizer62$902
Merck52$740
Boehringer Ingelheim35$557
Novartis28$515
Amgen(2 entities)29$489
Johnson & Johnson35$481
Sanofi-aventis U.S. LLC32$474
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC33$465
Corcept Therapeutics26$447
Bayer22$406
Exact Sciences20$406
GSK22$367
Organogenesis Inc.2$367
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)16$316
Takeda Pharmaceuticals U.S.A., Inc.12$275
Xeris Pharmaceuticals, Inc.14$249
Abbott12$223
Insulet Corporation8$181
Sumitomo Pharma America, Inc.8$176
Amarin Pharma, Inc.11$162
Astellas Pharma US Inc6$158
Paratek Pharmaceuticals, Inc.10$138
Kowa Pharmaceuticals America, Inc.10$122
Mylan Specialty L.p.6$96
Seqirus USA Inc4$96
Sunovion Pharmaceuticals Inc.4$88
Lexicon Pharmaceuticals, Inc.4$84
Eisai Inc.5$76
Esperion Therapeutics, Inc.5$72
Phathom Pharmaceuticals, Inc.5$46
Biohaven Pharmaceutical Holding Company Ltd.2$45
E.r. Squibb & Sons, L.L.C.3$44
Supernus Pharmaceuticals, Inc.3$42
Shield Therapeutics Inc2$38
Biohaven Pharmaceuticals, Inc.2$31
Axsome Therapeutics, Inc.2$30
Lundbeck LLC1$24
Urovant Sciences Inc1$22
Scilex Pharmaceuticals Inc.1$22
Alnylam Pharmaceuticals Inc.1$20
MDD US Operations, LLC1$18
Otsuka America Pharmaceutical, Inc.1$18
Viiv Healthcare Company1$17
Jazz Pharmaceuticals Inc.1$16
Phadia US Inc.1$14
Shire North American Group Inc1$13
Upsher-smith Laboratories LLC1$12
Edwards Lifesciences1$12
Currax Pharmaceuticals LLC1$12
Ironwood Pharmaceuticals, Inc1$12
Smith+Nephew1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,291 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$575,813
Medicare patients
838
Services billed
11,727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide415$571,509
EliquisApixaban483$410,625
OzempicSemaglutide282$355,854
JardianceEmpagliflozin339$343,217
TrulicityDulaglutide188$273,524
FarxigaDapagliflozin Propanediol218$178,715
JanuviaSitagliptin Phosphate183$176,091
EntrestoSacubitril/Valsartan173$153,846
LinzessLinaclotide204$142,990
XareltoRivaroxaban139$116,570
Trelegy ElliptaFluticasone/Umeclidin/Vilanter113$88,582
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog112$81,459
Breztri AerosphereBudesonide/Glycopyr/Formoterol86$68,270
MyrbetriqMirabegron121$68,062
RybelsusSemaglutide46$58,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,313$845,033603 claims
PfizerEliquis, Nurtec Odt, Premarin$902$446,248531 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$557$418,275425 claims
Novo NordiskOzempic, Rybelsus$1,647$414,611328 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Lokelma$1,305$277,894391 claims
AbbVieLinzess, Vraylar$2,379$200,716240 claims
MerckJanuvia$740$176,091183 claims
NovartisEntresto$515$153,846173 claims
Johnson & JohnsonXarelto$481$116,570139 claims
GSKTrelegy Ellipta, Breo Ellipta$367$111,765167 claims
Astellas Pharma US IncMyrbetriq$158$68,062121 claims
AmgenProlia$489$53,99031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Cheraw

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →